Triple-Hormone Synergy for Advanced Weight Management Research
🔬 Product Overview
Retatrutide is a cutting-edge triple hormone receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors. This multifaceted mechanism offers unparalleled potential in weight loss and metabolic health research. The 20mg vial provides a more cost-effective option for extended research protocols.
🚀 Key Benefits
Triple Hormone Activation: Engages GLP-1, GIP, and glucagon receptors to synergistically enhance weight loss and metabolic regulation.
Superior Weight Reduction: Clinical studies have demonstrated up to 24.2% body weight loss over 48 weeks with 12 mg dosing, surpassing results from other treatments like Ozempic and Mounjaro.
Enhanced Metabolic Health: Demonstrated improvements in liver fat content and cardiometabolic markers, indicating broader health benefits.
Cost Efficiency: Purchasing the 20mg vial reduces the cost per milligram compared to the 10mg option, offering better value for extended research needs.
🧪 Composition
Active Ingredient: Retatrutide
Concentration: 20mg per vial
Form: Lyophilized peptide powder
📦 Usage & Storage
Intended Use: For research purposes only
Storage: Store lyophilized powder in a cool, dry place. After reconstitution, refrigerate at 2–8°C and use within the designated study period.
🛒 Order your 20mg Retatrutide today for £350
